1Hunt RH. Importance of pH control in the management of GERD[J]. Arch Intern Med, 1999, 159 (7):649-657.
2Devault KR, Castell DO. The Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease[J]. Am J Gastroenterol, 1999,94(6): 1434- 1442.
3Janczewska l,Sager M. Comparison of the effect of lasoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroe-sophageal reflux disease[J]. Scand J Gastroenterol,1998,33(12):1239-1243.
4Dent J, Yeomans ND, Mackinnon M et al. Omeprazole ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety[J]. Gut, 1994,35(5) : 590-598.
5Richter JE, Long JF. Cisapride for gastroesphageal reflux disease; Aplacebo-controlled, double-blind study[J]. Am J Gastroenterol, 1995, 90 (3): 423-430.
6Vigneri S,Termini R,Leandro Get al. A comparison of five maintenance therapies for reflux esophagitis[J]. N Engl J Med,1995,333(17):1106-1110.
7Andersson T, Rohss K, Hassan-Alin M, et al. Pharmackinettics (PK) and dose-reponse relationship of esomeprazole [ J ]. Gastroenterology, 2000,118: 5550.
8Zsolt T, Andfrze J, Petr D, et al. One week esomeprazole-based triple therapy eridication Helicobacter pylori and heals patients with duodenal ulcer disease [ J ]. Eur J Gastroenteral Hepatol,2001,13(12): 1457.
